EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...
Did you miss the most popular gastroenterology stories this year? Medscape Medical News tracked the news most popular with ...
MedPage Today on MSN
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate ...
South Korea: In a post hoc analysis of the randomized PULSAR trial, aflibercept 8 mg demonstrated noninferior visual outcomes ...
The researchers also examined potential health risks linked to cannabis use. Long-term data from adolescents suggested that ...
Many disease-causing bacteria, viruses or fungi live on cloth, plastic and metal objects in your bathroom. Here's what you ...
Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...
HHS Secretary Robert F. Kennedy Jr.s CDC just funneled a $1.6 million dollar grant to researchers to carry out an unethical and scientifically unjustified randomized clinical trial of the birth dose o ...
Tenax Therapeutics, Inc. (Nasdaq: TENX) ("Tenax” or "Tenax Therapeutics” or the "Company”), a Phase 3, development-stage ...
As highly effective anti-obesity therapies emerge and regulatory expectations evolve, sponsors are adopting innovative trial designs, addressing long-term weight maintenance, monitoring lean mass ...
Study Finds on MSN
Menopause hormone therapy and brain health: What research on 1 million women tells us
A tenuous connection between hormone therapy and increased dementia risk was noted, but more research is warranted. In A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback